Enhance your practice with CME and tools that focus on diseases and conditions impacting the female patient.
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Minimal By Design: Define MSE Endpoints
Escalate With Intention: Stepwise, Target-Anchored Moves
Shared Goals, Shared Gains: Align With Patient Preferences
The 2-Point Signal: Apply ≥2-Point Rule
FcRn: Same Class, Different Paths—Spot Agent Differentiators
When to Begin FcRn: Initiation Criteria, Key Evidence
Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden
Gideon Hirschfield, MB, BChir, PhD
Marlyn Mayo, MD
Target Locked in gMG: Why T2T Matters
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Kenneth J. Moise Jr., MD
Kara B. Markham, MD
Not Just a Headache: Migraine Across Women’s Lifespan
Jelena Pavlović, MD, PhD
Amaal J. Starling, MD, FAHS, FAAN
ENDOVOICE Live: Endometriosis—A Chronic Burden of Reproductive Years
Linda Bradley, MD
Obianuju Sandra Madueke-Laveaux, MD, MPH
Lauren R. Kornegay
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
Alison Kole, MD, MPH, FACCP
Ghada Bourjeily, MD, FCCP
Rashmi Nisha Aurora, MD
Audrey Wells, MD
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Sawsan As-Sanie, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
The IgG Clock: Redose Using IgG Kinetics
Turning Flares Into Function: Flag Uncontrolled Disease
Diagnosing and Treating IBS: It Begins With One Simple Question
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Kimberly D. Orleck, PA-C
The Alloimmune Disorders of Pregnancy: Optimizing Fetal Outcomes Through Advances in Diagnosis and Treatment
William Goodnight, MD, MSCR
The Alloimmune Disorders of Pregnancy
Karin J. Blakemore, MD
Emilie L. Vander Haar
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Lee P. Shulman, MD, FACMG, FACOG
Samantha Denäe
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Melissa Simon, MD
Casey Joe Hinds
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Pre- and Postoperative Use of GnRH Antagonists
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
Alexandra Benachi, MD, PhD
Julien Zuber, MD, PhD
Alloimmune Thrombocytopenia in the Fetus and Newborn
James B. Bussel, MD
Unmasking Preeclampsia, the Great Masquerader
Mario R. Nacinovich, Jr., MSc
Kara Rood, MD
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.